JP2012522989A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2012522989A5 JP2012522989A5 JP2012503660A JP2012503660A JP2012522989A5 JP 2012522989 A5 JP2012522989 A5 JP 2012522989A5 JP 2012503660 A JP2012503660 A JP 2012503660A JP 2012503660 A JP2012503660 A JP 2012503660A JP 2012522989 A5 JP2012522989 A5 JP 2012522989A5
- Authority
- JP
- Japan
- Prior art keywords
- biomarkers
- subject
- level
- acid
- sample
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US16533609P | 2009-03-31 | 2009-03-31 | |
| US61/165,336 | 2009-03-31 | ||
| US16657209P | 2009-04-03 | 2009-04-03 | |
| US61/166,572 | 2009-04-03 | ||
| PCT/US2010/029399 WO2010114897A1 (en) | 2009-03-31 | 2010-03-31 | Biomarkers related to insulin resistance and methods using the same |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2012522989A JP2012522989A (ja) | 2012-09-27 |
| JP2012522989A5 true JP2012522989A5 (enExample) | 2013-01-17 |
Family
ID=42828685
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2012503660A Pending JP2012522989A (ja) | 2009-03-31 | 2010-03-31 | インスリン抵抗性に関連するバイオマーカー、及びそれを使用する方法 |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US20120122981A1 (enExample) |
| EP (1) | EP2414535A4 (enExample) |
| JP (1) | JP2012522989A (enExample) |
| CN (1) | CN102449161A (enExample) |
| BR (1) | BRPI1013387A2 (enExample) |
| WO (1) | WO2010114897A1 (enExample) |
Families Citing this family (39)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2009001862A1 (ja) * | 2007-06-25 | 2008-12-31 | Ajinomoto Co., Inc. | 内臓脂肪蓄積の評価方法 |
| MX2010000414A (es) | 2007-07-17 | 2010-04-01 | Metabolon Inc | Biomarcadores para prediabetes, enfermedades cardiovasculares y otros trastornos relacionados con sindrome metabolico, y metodos de uso de los mismos. |
| US10215765B2 (en) | 2010-09-15 | 2019-02-26 | Quest Diagnostics Investments Incorporated | Detection of vitamins A and E by tandem mass spectrometry |
| WO2012058298A1 (en) * | 2010-10-26 | 2012-05-03 | Mayo Foundation For Medical Education And Research | Biomarkers of reduced insulin action |
| KR101303825B1 (ko) * | 2011-06-02 | 2013-09-05 | 연세대학교 산학협력단 | 혈장 대사체를 이용한 제2형 당뇨병 진단 키트 |
| WO2013002381A1 (ja) | 2011-06-30 | 2013-01-03 | 味の素株式会社 | 脂肪性肝疾患の評価方法、脂肪性肝疾患評価装置、脂肪性肝疾患評価方法、脂肪性肝疾患評価プログラム、脂肪性肝疾患評価システム、情報通信端末装置、および脂肪性肝疾患の予防・改善物質の探索方法 |
| JP6158186B2 (ja) * | 2011-09-14 | 2017-07-05 | メタボロン，インコーポレイテッド | インスリン抵抗性に関連するバイオマーカーおよびそれを使用する方法 |
| EP2642293A1 (en) | 2012-03-22 | 2013-09-25 | Nestec S.A. | 9-oxo-octadecadienoic acid (9-oxo-HODE)as as biomarker for healthy ageing |
| EP2642295A1 (en) * | 2012-03-22 | 2013-09-25 | Nestec S.A. | 1-O-alkyl-2-acylglycerophosphocholine (PC-O) 40:1 as biomarker for healthy ageing |
| US9361429B2 (en) | 2012-06-08 | 2016-06-07 | Liposcience, Inc. | Multi-parameter diabetes risk evaluations |
| US9470771B2 (en) | 2012-06-08 | 2016-10-18 | Liposcience, Inc. | NMR measurements of NMR biomarker GlycA |
| US9928345B2 (en) | 2012-06-08 | 2018-03-27 | Liposciences, Inc. | Multiple-marker risk parameters predictive of conversion to diabetes |
| US9546994B2 (en) * | 2012-08-13 | 2017-01-17 | Helmholtz Zentrum Munchen-Deutsches Forschungszentrum fur Geseundheit und Umwelt (GmbH) | Biomarkers for type 2 diabetes |
| US20140324460A1 (en) * | 2012-09-26 | 2014-10-30 | Health Diagnostic Laboratory, Inc. | Method for determining and managing total cardiodiabetes risk |
| EP2939024B1 (en) * | 2012-12-26 | 2021-04-28 | Quest Diagnostics Investments Incorporated | C peptide detection by mass spectrometry |
| US10191032B2 (en) | 2013-01-11 | 2019-01-29 | True Health Ip Llc | Method of detection and treatment of clinically significant post-prandial hyperglycemia in normoglycemic patients |
| US9910047B2 (en) | 2013-01-31 | 2018-03-06 | Metabolon, Inc. | Biomarkers related to insulin resistance progression and methods using the same |
| US20140278121A1 (en) * | 2013-03-13 | 2014-09-18 | Robust for Life, Inc. | Systems and methods for network-based calculation and reporting of metabolic risk |
| WO2015057315A1 (en) * | 2013-09-04 | 2015-04-23 | Kelly Joseph Michael Lawless | Methods and systems for the detection of disease |
| CA2945165A1 (en) * | 2014-04-08 | 2015-10-15 | Metabolon, Inc. | Small molecule biochemical profiling of individual subjects for disease diagnosis and health assessment |
| JP6051258B2 (ja) * | 2015-04-15 | 2016-12-27 | ライオン株式会社 | 脂質異常症への罹患しやすさを試験する方法 |
| JP6051257B2 (ja) * | 2015-04-15 | 2016-12-27 | ライオン株式会社 | 脂質異常症への罹患しやすさを試験する方法 |
| US10884005B2 (en) * | 2015-10-18 | 2021-01-05 | Wei Jia | Diabetes-related biomarkers and treatment of diabetes-related conditions |
| GB201522302D0 (en) * | 2015-12-17 | 2016-02-03 | Mars Inc | Food product for regulating lipid metabolites |
| CN106093430A (zh) * | 2016-06-06 | 2016-11-09 | 上海阿趣生物科技有限公司 | 可用于检测糖尿病的标志物及其用途 |
| CN107022018B (zh) * | 2016-08-16 | 2018-04-13 | 北京毅新博创生物科技有限公司 | 检测胰岛素抵抗的组合物及产品和用途 |
| CN106442770B (zh) * | 2016-09-05 | 2019-01-18 | 南京医科大学 | 与特发性男性不育相关的精浆代谢小分子标志物及其检测方法和应用 |
| CN106908605B (zh) * | 2017-01-22 | 2019-02-22 | 中国人民解放军军事医学科学院基础医学研究所 | eLtaS蛋白作为预防和治疗胰岛素抵抗相关疾病的药物靶点的应用 |
| US20200174022A1 (en) * | 2017-08-17 | 2020-06-04 | Societe Des Produits Nestle S.A. | Markers in prepuberty for childhood-prediabetes |
| CN108623655B (zh) * | 2018-05-15 | 2020-09-01 | 浙江省农业科学院 | 改善胰岛素抵抗的二肽el及其用途 |
| CN109298084A (zh) * | 2018-07-23 | 2019-02-01 | 上海市东方医院 | 用于检测血清或者血浆中油酸浓度的试剂盒及其制备方法和应用 |
| JP2022501579A (ja) * | 2018-09-27 | 2022-01-06 | ソシエテ・デ・プロデュイ・ネスレ・エス・アー | 小児期及び若年成人期においてインスリン抵抗性を発症するリスクについてのマーカー |
| CN110887808A (zh) * | 2019-10-28 | 2020-03-17 | 广东省测试分析研究所（中国广州分析测试中心） | 一种红外光谱技术快速检测阿卡波糖发酵过程中的糖源含量的方法 |
| CN112903885B (zh) * | 2019-12-03 | 2022-05-06 | 中国科学院大连化学物理研究所 | 一种筛查糖尿病的联合型代谢标志物的应用及其试剂盒 |
| CN213980949U (zh) | 2020-08-27 | 2021-08-17 | 康明斯电力公司 | 用于发电机组的系统 |
| CN112461986B (zh) * | 2021-02-03 | 2021-06-08 | 首都医科大学附属北京友谊医院 | 一种用于评估空腹血糖受损和2型糖尿病患病风险的整合生物标志物体系 |
| EP3922990B1 (en) | 2021-03-28 | 2024-05-08 | MS Ekspert Sp. z o.o. | System for automatic changing and sealing of disposable chromatographic columns in high-performance liquid chromatography; measurement method and its application in the analysis of biomarker of rare disease |
| CN113929762B (zh) * | 2021-12-16 | 2022-04-26 | 清华大学 | 3-羟基丁酰化和/或3-羟基戊酰化修饰胰岛素及其应用 |
| CN117159717A (zh) * | 2023-09-28 | 2023-12-05 | 广东省人民医院 | Slc25a33在制备预防或治疗葡萄糖代谢相关疾病的药物中的应用 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR19990007908A (ko) * | 1996-02-20 | 1999-01-25 | 히라다다다시 | 1,5-안히드로글루시톨의 정량법 |
| CN1533435A (zh) * | 2001-06-01 | 2004-09-29 | 克林杰尼克斯公司 | 用于诊断及治疗胰岛素抗性及相关病症之方法和试剂 |
| US7425545B2 (en) * | 2001-07-25 | 2008-09-16 | Isis Pharmaceuticals, Inc. | Modulation of C-reactive protein expression |
| BRPI0807612A2 (pt) * | 2007-02-22 | 2015-06-16 | Tethys Bioscience Inc | Marcadores metabólicos de condições diabéticas e métodos de uso do mesmo |
| MX2010000414A (es) * | 2007-07-17 | 2010-04-01 | Metabolon Inc | Biomarcadores para prediabetes, enfermedades cardiovasculares y otros trastornos relacionados con sindrome metabolico, y metodos de uso de los mismos. |
-
2010
- 2010-03-31 JP JP2012503660A patent/JP2012522989A/ja active Pending
- 2010-03-31 WO PCT/US2010/029399 patent/WO2010114897A1/en not_active Ceased
- 2010-03-31 CN CN2010800240217A patent/CN102449161A/zh active Pending
- 2010-03-31 BR BRPI1013387-9A patent/BRPI1013387A2/pt not_active Application Discontinuation
- 2010-03-31 US US13/258,780 patent/US20120122981A1/en not_active Abandoned
- 2010-03-31 EP EP10759343A patent/EP2414535A4/en not_active Withdrawn
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2015064362A5 (enExample) | ||
| JP6927212B2 (ja) | 軽度認知障害又はアルツハイマー型認知症の評価方法 | |
| Lehmann et al. | Circulating lysophosphatidylcholines are markers of a metabolically benign nonalcoholic fatty liver | |
| EP2427773B1 (en) | Method of diagnosing asphyxia | |
| Tsang et al. | Metabolic characterization of the R6/2 transgenic mouse model of Huntington's disease by high-resolution MAS 1H NMR spectroscopy | |
| JP2010537157A5 (enExample) | ||
| JP6870679B2 (ja) | アルツハイマー型認知症の将来の発症リスクの評価方法 | |
| JP2016509222A (ja) | インスリン抵抗性の進行に関連するバイオマーカー及びこれを使用する方法 | |
| Zhang et al. | Machine learning applied to serum and cerebrospinal fluid metabolomes revealed altered arginine metabolism in neonatal sepsis with meningoencephalitis | |
| JP7123329B2 (ja) | 腎臓病の予後予測方法及びシステム | |
| Cassol et al. | Altered monoamine and acylcarnitine metabolites in HIV-positive and HIV-negative subjects with depression | |
| CN102449161A (zh) | 与胰岛素抵抗有关的生物标记和使用该生物标记的方法 | |
| Liu et al. | Dynamic proteomic analysis of protein expression profiles in whole brain of Balb/C mice subjected to unpredictable chronic mild stress: implications for depressive disorders and future therapies | |
| JP2014532168A5 (enExample) | ||
| JP2012521551A5 (enExample) | ||
| Yang et al. | Metabolomics in viral hepatitis: advances and review | |
| ES2749048T3 (es) | Biomarcadores para evaluar el VIH | |
| CN103837620A (zh) | 一种同时检测人体血浆中多种氨基酸含量的方法 | |
| JP6762529B2 (ja) | 腎臓病の病態バイオマーカー | |
| Han et al. | Plasma advanced glycation endproduct, methylglyoxal-derived hydroimidazolone is elevated in young, complication-free patients with Type 1 diabetes | |
| Bratt et al. | Arginase enzymes in isolated airways from normal and nitric oxide synthase 2-knockout mice exposed to ovalbumin | |
| Zheng et al. | Urinary and faecal metabolic characteristics in APP/PS1 transgenic mouse model of Alzheimer's disease with and without cognitive decline | |
| WO2015030211A1 (ja) | 疲労のバイオマーカーおよびその利用 | |
| Gonçalves et al. | Comparative salivary proteome of hepatitis B-and C-infected patients | |
| CN108508106A (zh) | 生活习惯病的生物标志物及其用途、和存储介质 |